A. Stewart

Race/ethnic differences in Alzheimer disease survival in US Alzheimer Disease Centers

K. Yaffe, B. Miller, D. Barnes, 2010 .

Cardiovascular disease and chimeric antigen receptor cellular therapy

Kathleen W. Zhang, F. Awan, A. Chandra, 2022, Frontiers in Cardiovascular Medicine.

Survival and long-term outcomes in late-onset Pompe disease following alglucosidase alfa treatment: a systematic review and meta-analysis

A. Hamed, J. Jansen, B. Schoser, 2016, Journal of Neurology.

Qualitative interviews to improve patient-reported outcome measures in late-onset Pompe disease: the patient perspective

A. Hamed, J. Paty, C. Gwaltney, 2021, Orphanet Journal of Rare Diseases.

Forced vital capacity and cross-domain late-onset Pompe disease outcomes: an individual patient-level data meta-analysis

A. Hamed, J. Jansen, S. Kanters, 2019, Journal of Neurology.

Survival and long-term outcomes in late-onset Pompe disease following alglucosidase alfa treatment: a systematic review and meta-analysis

A. Hamed, J. Jansen, B. Schoser, 2016, Journal of Neurology.